Andrew Ortega-Verdaguer, MSc, BSc

Andrew Ortega-Verdaguer has a diverse work experience in the healthcare industry. Andrew is currently serving as the Chief Operations Officer at NIMBLE Diagnostics. Prior to this, they worked at Penumbra, Inc. where they held two roles. Andrew was the EMEA Marketing Leader for the Vascular Franchise, responsible for improving the lives of patients with acute limb ischemia, deep venous thrombosis, and pulmonary embolism. Andrew also served as the International Strategy Manager. Before Penumbra, they worked at Terumo Aortic as a Senior Global Marketing Manager. Earlier in their career, they worked at Novartis as a Sales Representative, specializing in various diseases and earning recognition for their sales performance. Andrew also served as a Brand Manager during their tenure at Novartis. Their earlier experience includes a role as a Product Manager at Almirall.

Andrew Ortega-Verdaguer holds a Master of Science (MSc) degree in Pharmaceutical Marketing and Management from Universitat de Barcelona, which they obtained from 2010 to 2012. Andrew also holds a Bachelor of Science (BSc) degree in Molecular Biology from Universitat de Girona, which they obtained from 2005 to 2010.

In terms of additional education, Andrew completed the IGNITE Program at Stanford University Graduate School of Business in 2023 and obtained certifications in "Building High-Performance Teams" and "How to Write a Marketing Plan" from LinkedIn in January 2023. Andrew also completed the Leading People and Teams program at the University of Michigan in 2020 and the Leading Strategic Initiatives program at IMD in 2016.

Furthermore, Andrew obtained a certification in "Neuro-Linguistic Programming for Persuasion" from PNL Barcelona in 2015. Additionally, they earned the "Stanford Ignite" certification from Stanford University Graduate School of Business, though the specific details are not provided.